medicine

Research into the development of Ebola vaccines, efforts to address opioid use among women, infectious diseases and a record number of novel drug approvals are among the many examples of federal health agencies making tremendous strides in 2017 to address complex and deadly health threats. The agencies highlighted their achievements in year-end articles, videos and reports on their websites. The National Institutes of Health (NIH) described progress with two Ebola vaccines and a bionic pancreas to better treat type 1 diabetes in addition to other clinical advances. The NIH also supported the work of three recipients of the Nobel Prize in Physiology or Medicine and one recipient of the Nobel...
Chronic diseases are a formidable public health challenge for the U.S. with more than 50 percent of Americans living daily with one or more chronic health conditions. The impact of these illnesses can be debilitating for individuals, families and local communities. Approximately 75 cents of every dollar spent on health care in 2009 was related to chronic illnesses which totaled $1.7 trillion . The main weapon available to treat chronic diseases, such as diabetes or high blood pressure, is medications. The average number of medications prescribed per capita increased from 10.1 in 1999 to 12.7 in 2014 . In fact, one of the most effective means to improve health outcomes is to ensure...
"There's not one fix" to ensuring patient access to innovative medicine. That appeared to be the consensus of moderator Christi Shaw, president, Novartis Pharmaceuticals Corporation and panelists, discussing the opportunities and challenges in getting new therapies to patients with complex and chronic conditions like cancer, multiple sclerosis and rheumatoid arthritis during a super session today at the BIO International Convention. Is the cost of some drugs a barrier? Are we adequately pricing the value of innovation? To ensure breakthroughs continue to reach patients, Scott Gottlieb, resident fellow, American Enterprise Institute, suggested that we need an approach to financing care that'...

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America